Eikon Therapeutics (EIKN)

• Market cap: $568M
• 1 day: -4.88%
• 5 days: -4.71%
• 1 month: -22.8%
• 3 months: -29.8%
• 6 months: -29.8%
• Year to date: -29.8%
• 1 year: -29.8%
• 5 years: -29.8%
• 10 years: -29.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.